{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:48:27Z","timestamp":1791488907018,"version":"4.3.4"},"reference-count":27,"publisher":"BMJ","issue":"7","funder":[{"name":"Daewoong Pharmaceutical"},{"DOI":"10.13039\/100007478","name":"Cardiovascular Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007478","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Daiichi-Sankyo"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2025,8,20]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The impact of off-label underdosing of direct oral anticoagulants (DOACs) on clinical outcomes in patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The EPIC-CAD trial (Edoxaban vs Edoxaban with antiPlatelet agent In patients with atrial fibrillation and Chronic stable Coronary Artery Disease) randomised patients with AF and stable CAD to receive either edoxaban monotherapy or dual antithrombotic therapy (edoxaban plus single antiplatelet agent). Off-label underdosing was defined as low-dose edoxaban (30\u2009mg once daily) without standard criteria for dose reduction. The primary outcome was a composite of death, myocardial infarction, stroke, systemic embolism, unplanned revascularisation and major or clinically relevant non-major bleeding at 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 1040 randomised patients, 694 patients (66.7%) without dose-reduction criteria were included; of whom, 121 patients (17.4%) received edoxaban underdosing. At 12 months, the incidence of primary outcome was similar between standard-dose and under-dose edoxaban groups (10.5% vs 9.2%, adjusted HR 0.77, 95% CI 0.39 to 1.54). There was no significant difference in major ischaemic events (1.4% vs 1.7%, HR 1.14, 95%\u2009CI 0.22 to 5.91) and major or clinically relevant non-major bleeding (9.0% vs 8.4%, HR 0.87, 95%\u2009CI 0.42 to 1.78). Regardless of edoxaban underdosing, edoxaban monotherapy was associated with lower risk of primary net-clinical outcomes and bleeding compared with dual antithrombotic therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with AF and stable CAD, there was no significant difference in the rate of primary outcome between off-label underdose and standard-dose edoxaban. The benefit of edoxaban monotherapy over dual antithrombotic therapy was consistent regardless of edoxaban underdosing. However, given the analyses were underpowered and the CI was wide, the results cannot be considered clinically directive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      URL:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\">https:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n                      ; unique identifiers:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03718559\">NCT03718559<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2025-326646","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T13:03:57Z","timestamp":1759928637000},"page":"391-398","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial"],"prefix":"10.1136","volume":"112","clinical-trial-number":[{"clinical-trial-number":"nct03718559","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9867-4991","authenticated-orcid":false,"given":"Min Soo","family":"Cho","sequence":"first","affiliation":[{"name":"Heart Institute, Asan Medical Center, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-0562","authenticated-orcid":false,"given":"Do-Yoon","family":"Kang","sequence":"additional","affiliation":[{"name":"Asan Medical Center, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Bok","family":"Lee","sequence":"additional","affiliation":[{"name":"Asan Medical Center, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5323-3428","authenticated-orcid":false,"given":"Yong-Seog","family":"Oh","sequence":"additional","affiliation":[{"name":"The Catholic University of Korea Seoul St Mary\u2019s Hospital, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hoon","family":"Lee","sequence":"additional","affiliation":[{"name":"Veterans Health Service Medical Centre, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-6372","authenticated-orcid":false,"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Cardiology, Bundang Seoul National University Hospital Department of Internal Medicine, Seongnam, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hee","family":"Kwon","sequence":"additional","affiliation":[{"name":"Cardiology, Konkuk University Medical Center, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5846-0606","authenticated-orcid":false,"given":"Gyung-Min","family":"Park","sequence":"additional","affiliation":[{"name":"Cardiology, Ulsan University Hospital, Ulsan, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Oh","family":"Choi","sequence":"additional","affiliation":[{"name":"Cardiology, Soonchunhyang University Hospital, Bucheon, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Ha","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiology, Hallym University Medical Center, Anyang, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Min","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Medicine, Samsung Medical Center, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongmin","family":"Hwang","sequence":"additional","affiliation":[{"name":"Keimyung University Dongsan Hospital, Daegu, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Dong","family":"Yoo","sequence":"additional","affiliation":[{"name":"Internal Medicine, Catholic University of Korea Saint Vincent\u2019s Hospital, Suwon, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Rak","family":"Cho","sequence":"additional","affiliation":[{"name":"Dong-A University Medical Center, Dong-A University College of Medicine, Busan, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Internal medicine, Dongguk University Ilsan Hospital, Goyang, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Won","family":"Hwang","sequence":"additional","affiliation":[{"name":"Pusan National University Yangsan Hospital, Yangsan, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sun","family":"Jin","sequence":"additional","affiliation":[{"name":"Kyung Hee University Gangdong Hospital, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osung","family":"Kwon","sequence":"additional","affiliation":[{"name":"Cardiology, The Catholic University of Korea Eunpyeong St Mary\u2019s Hospital, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Hun","family":"Kim","sequence":"additional","affiliation":[{"name":"Haeundae Paik Hospital, Busan, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6643-0239","authenticated-orcid":false,"given":"Duk-Woo","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Ulsan College of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5354-2554","authenticated-orcid":false,"given":"Gi-Byoung","family":"Nam","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Ulsan College of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"2026031202100616000_112.7.391.1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"2026031202100616000_112.7.391.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193"},{"key":"2026031202100616000_112.7.391.3","unstructured":"Van Gelder IC , Rienstra M , Bunting KV , et al . 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J 2024.:ehae176."},{"key":"2026031202100616000_112.7.391.4","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.amjcard.2020.01.044","article-title":"Pattern and Impact of Off-label Underdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Who are Indicated for Standard Dosing","volume":"125","author":"Cho","year":"2020","journal-title":"Am J Cardiol"},{"key":"2026031202100616000_112.7.391.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.966"},{"key":"2026031202100616000_112.7.391.6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jacc.2020.12.053","article-title":"Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation","volume":"77","author":"Steffel","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026031202100616000_112.7.391.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.07.045"},{"key":"2026031202100616000_112.7.391.8","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad302","article-title":"Characteristics of patients with atrial fibrillation treated with direct oral anticoagulants and new insights into inappropriate dosing: results from the French National Prospective Registry: PAFF","volume":"25","author":"Guenoun","year":"2023","journal-title":"Europace"},{"key":"2026031202100616000_112.7.391.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612"},{"key":"2026031202100616000_112.7.391.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407362"},{"key":"2026031202100616000_112.7.391.11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2022.01.014","article-title":"Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial","volume":"247","author":"Cho","year":"2022","journal-title":"Am Heart J"},{"key":"2026031202100616000_112.7.391.12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal Structural Models and Causal Inference in Epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology (Sunnyvale)"},{"key":"2026031202100616000_112.7.391.13","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5753"},{"key":"2026031202100616000_112.7.391.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.032"},{"key":"2026031202100616000_112.7.391.15","unstructured":"Ridgeway G , McCaffrey DF , Morral AR , et al . Toolkit for weighting and analysis of nonequivalent groups: a tutorial for the r twang package. Rand Santa Monica, Calif; 2022."},{"key":"2026031202100616000_112.7.391.16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3349\/ymj.2019.60.3.277","article-title":"Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation","volume":"60","author":"Lee","year":"2019","journal-title":"Yonsei Med J"},{"key":"2026031202100616000_112.7.391.17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11239-019-01934-6","article-title":"Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings","volume":"48","author":"Ikeda","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"2026031202100616000_112.7.391.18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamacardio.2020.6814","article-title":"Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model","volume":"6","author":"Urban","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026031202100616000_112.7.391.19","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007971","article-title":"Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis","volume":"14","author":"Zhang","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026031202100616000_112.7.391.20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ahj.2021.12.017","article-title":"Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups","volume":"247","author":"Gencer","year":"2022","journal-title":"Am Heart J"},{"key":"2026031202100616000_112.7.391.21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.17156","article-title":"Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation","volume":"6","author":"Rymer","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026031202100616000_112.7.391.22","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.991293","article-title":"Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease","volume":"9","author":"Lee","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026031202100616000_112.7.391.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904143"},{"key":"2026031202100616000_112.7.391.24","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1055\/s-0042-1744543","article-title":"Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings","volume":"122","author":"Arashi","year":"2022","journal-title":"Thromb Haemost"},{"key":"2026031202100616000_112.7.391.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709118"},{"key":"2026031202100616000_112.7.391.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112277"},{"key":"2026031202100616000_112.7.391.27","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2025-326646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:20:34Z","timestamp":1773332434000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2025-326646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,3,12]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/heartjnl-2025-326646"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2025-326646","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]}}}